1 Anesthesiology Department, "Saint Luke" Private Hospital, Thessaloniki, Greece ; 2 Pulmonary-Oncology, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece ; 3 Oncology Department, "Interbalkan" European Medical Center, Thessaloniki, Greece ; 4 2nd Pulmonary Clinic of "Sotiria" Hospital, Athens, Greece ; 5 Pulmonary Laboratory of Alexandra Hospital University of Athens, Athens, Greece ; 6 Surgery Department, University General Hospital of Alexandroupolis, Alexandroupolis, Greece ; 7 Thoracic Surgery Department, "Saint Luke" Private Hospital, Thessaloniki, Greece ; 8 Ear, Nose and Throat, "Saint Luke" Private Hospital, Panorama, Thessaloniki, Greece ; 9 Thoracic Surgery Department, Theagenio Cancer Hospital, Thessaloniki, Greece ; 10 Nuclear Medicine Department, University General Hospital of Alexandroupolis, Democritus University of Thrace, Greece ; 11 Clinic for Thoracic Surgery, The Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, University of Novi Sad, Serbia.
Ann Transl Med. 2015 Mar;3(3):40. doi: 10.3978/j.issn.2305-5839.2015.02.11.
The central venous catheter (CVC) is a catheter placed into a large vein in the neck [internal jugular vein (IJV)], chest (subclavian vein or axillary vein) or groin (femoral vein). There are several situations that require the insertion of a CVC mainly to administer medications or fluids, obtain blood tests (specifically the "central venous oxygen saturation"), and measure central venous pressure. CVC usually remain in place for a longer period of time than other venous access devices. There are situations according to the drug administration or length of stay of the catheter that specific systems are indicated such as; a Hickman line, a peripherally inserted central catheter (PICC) line or a Port-a-Cath may be considered because of their smaller infection risk. Sterile technique is highly important here, as a line may serve as a port of entry for pathogenic organisms, and the line itself may become infected with organisms such as Staphylococcus aureus and coagulase-negative Staphylococci. In the current review we will present the complication of pneumothorax after CVC insertion.
中心静脉导管（CVC）是一种插入颈部[颈内静脉（IJV）]、胸部（锁骨下静脉或腋静脉）或腹股沟（股静脉）大静脉的导管。有几种情况需要插入 CVC，主要是为了给药或输液、进行血液检查（特别是“中心静脉血氧饱和度”）和测量中心静脉压。CVC 通常比其他静脉通路装置留置时间更长。根据药物管理或导管留置时间，可能需要特定的系统，例如 Hickman 线、外周插入中心导管（PICC）线或 Port-a-Cath，因为它们的感染风险较小。这里高度重视无菌技术，因为导管可能成为病原体进入的门户，导管本身可能会感染金黄色葡萄球菌和凝固酶阴性葡萄球菌等病原体。在本次综述中，我们将介绍 CVC 插入后气胸的并发症。
